Chabiotech Co.,Ltd. (KOSDAQ:085660)
12,210
-130 (-1.05%)
Nov 7, 2025, 3:30 PM KST
Chabiotech Revenue
Chabiotech had revenue of 298.90B KRW in the quarter ending June 30, 2025, with 12.94% growth. This brings the company's revenue in the last twelve months to 1.15T, up 18.08% year-over-year. In the year 2024, Chabiotech had annual revenue of 1.05T with 9.55% growth.
Revenue (ttm)
1.15T
Revenue Growth
+18.08%
P/S Ratio
0.81
Revenue / Employee
4.14B
Employees
278
Market Cap
927.42B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.05T | 91.10B | 9.55% |
| Dec 31, 2023 | 953.95B | 109.37B | 12.95% |
| Dec 31, 2022 | 844.58B | 117.11B | 16.10% |
| Dec 31, 2021 | 727.48B | 62.76B | 9.44% |
| Dec 31, 2020 | 664.72B | 130.11B | 24.34% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 5.03T |
| Celltrion | 3.75T |
| Yuhan | 2.17T |
| Hanmi Pharm. | 1.50T |
| SK Biopharmaceuticals | 620.28B |
| Sam Chun Dang Pharm. | 215.10B |
| ALTEOGEN | 158.06B |
| LigaChem Biosciences | 148.28B |